Continuum Advisory’s VanEck Biotech ETF BBH Stock Holding History

Continuum Advisory’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$179K	Buy	+880	New	+$165K	0.01%	489
2026 Q1	–	Sell	-1,262	Closed	-$239K	–	455
2025 Q4	$239K	Buy	+1,262	New	+$233K	0.02%	407
2025 Q2	–	Sell	-1,304	Closed	-$205K	–	512
2025 Q1	$205K	Buy	1,304 +270	+26%	+$43.8K	0.03%	388
2024 Q4	$162K	Hold	1,034	–	–	0.02%	428
2024 Q3	$171K	Buy	1,034 +50	+5%	+$8.87K	0.02%	424
2024 Q2	$166K	Hold	984	–	–	0.02%	397
2024 Q1	$162K	Buy	+984	New	+$163K	0.02%	403
2021 Q4	–	Sell	-1,039	Closed	-$210K	–	304
2021 Q3	$210K	Buy	+1,039	New	+$218K	0.06%	274

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Continuum Advisory's BBH Position: Q2 2026 in Review

Continuum Advisory opened a new position in VanEck Biotech ETF (BBH) in Q2 2026: 880 shares worth $179K. The stake represents 0.01% of the portfolio and ranks #489 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in BBH as recently as Q4 2025.

Continuum Advisory first reported a position in BBH in Q3 2021 and has held it in 8 quarters since. The position peaked at $239K in Q4 2025. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

Continuum Advisory held 880 shares of VanEck Biotech ETF worth $179K as of Q2 2026.
VanEck Biotech ETF was a new Continuum Advisory position in Q2 2026.
VanEck Biotech ETF made up 0.01% of Continuum Advisory's portfolio in Q2 2026, its #489 holding.
Continuum Advisory first reported a position in VanEck Biotech ETF in Q3 2021 and has held it in 8 quarters since.
Continuum Advisory's VanEck Biotech ETF position peaked at $239K in Q4 2025.
110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.